Latest Percutaneous coronary intervention Stories
DALLAS, November 26, 2014 /PRNewswire/ -- The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative
A national effort to shave minutes off emergency heart attack treatment time has increased the chance that each patient will survive, a new study suggests. But yet the survival rate for all patients put together hasn’t budged.
Announces Formation of Angionetics and Activation Therapeutics: New Operating Units to Facilitate the Independent Monetization and Funding of Generx® and Excellagen® SAN DIEGO, Nov.
Prashant Kaul, M.D., of the University of North Carolina, Chapel Hill, and colleagues conducted a study to define the incidence and treatment and outcomes of patients who experience a certain type of heart attack during hospitalization for conditions other than acute coronary syndromes.
-- Distribution Agreement Secured with STENTYS -- DURHAM, N.C., Nov. 3, 2014 /PRNewswire/ -- Micell Technologies, Inc.
Latest report by ChinaMarketResearchReports.com, "China Interventional Cardiovascular Device Industry Report, 2014-2017" now available in their store. Dallas,
The North American interventional cardiology devices market study covers the surgical and diagnostic devices market for angioplasty, aneurysm repair, and deep vein thrombosis procedures.
A coronary angiography, also known as a coronary catheterization, is a procedure that gives both visual and tactical access to coronary circulation and blood filled chambers of the heart for both diagnostic and interventional purposes. It is one of many diagnostic tests used in cardiology. More specifically, coronary catheterization recognizes occlusion, stenosis, thrombosis or aneurismal enlargement of the walls of the coronary arteries; heart chamber size; heart muscle contraction...
- A political dynamiter.